This analysis for Structure Therapeutics (GPCR) reports a strong buy signal since September 16, 2025, with a score of 7.39. The stock has gained 8.21% in the past four days, averaging 2.05% daily. The analyst expects the 3-month trend may change to 3.15%, with a possible range from -27.63% to 3.15%. A 12-month analysis projects a -53.78% change, ranging from -92.01% to -62.60%. The stock ended the last trading day at $23.58, rising 1.51%, with a 4.14% fluctuation. The 52-week range is $13.22 to $45.37. Recent news indicates sensitivity to market dynamics, and they are awaiting studies results. The overall recommendation for analyst sources is to sell. Some signals for signals includes bullish pivot and Bollinger signals, the recommenced stop loss is $22.74. Earnings are to be given on Nov. 12.